MGC Diagnostics and MTI Partner to Expand Connected Spirometry Beyond the Pulmonary Lab

St. Paul, MN, November 12, 2026 - MGC Diagnostics (MGC) and Monitored Therapeutics, Inc. (MTI) have partnered to make MTI's GoSpiro® and GoClinic® point-of-care spirometry solution available with Ascent Software Solutions™, MGC's connected pulmonary diagnostic ecosystem. Under the agreement, MGC will sell and support the GoSpiro and GoClinic solution for healthcare organizations in the United States, backed by MGC's best-in-class service.

Many patients with symptoms of COPD and asthma first present in primary and community care, far from the pulmonary function lab. Spirometry in those settings can be hard to perform consistently, and results often sit in standalone devices or apps, disconnected from the patient record. The MGC and MTI partnership is designed to close that gap.

Together, MTI's GoSpiro spirometer and GoClinic point-of-care platform connect with Ascent Software Solutions to create a standardized spirometry workflow extending from outpatient care settings to the pulmonary function laboratory. The workflow is designed to support spirometry performed in accordance with ATS/ERS 2019 technical standards. Built-in quality feedback and Lisa, MTI's real-time coaching technology, guide patients through the maneuver in more than 20 languages, helping staff obtain consistent, high-quality spirometry at the point of care.

Once testing is complete, results transfer through the GoClinic platform to Ascent Software Solutions for centralized clinical review and reporting alongside the patient's other respiratory testing. Ascent supports EMR integration, so point-of-care spirometry across multiple locations becomes part of the same workflow teams already use, from the handheld to the full PFT lab.

"By connecting GoSpiro and GoClinic with Ascent, we can help healthcare organizations bring spirometry closer to the point of care while maintaining the connected workflows their pulmonary teams need," said Corey Eckhoff, Senior Vice President, Sales and Marketing at MGC Diagnostics. "The partnership brings together portable testing, real-time coaching and centralized respiratory data in one scalable diagnostic ecosystem."

"High-quality spirometry should not depend on where a patient is tested or how much prior spirometry experience the operator has," said Michael Taylor, Chief Clinical Officer and Co-Founder of Monitored Therapeutics. "By combining GoSpiro, GoClinic and Lisa's real-time coaching with MGC Diagnostics' established pulmonary diagnostic ecosystem, we can help health systems standardize spirometry across more care settings while keeping pulmonary teams connected to the data."

See how GoSpiro, GoClinic and Ascent Software Solutions™ bring connected spirometry to every site of care. Request a Demo

About MGC Diagnostics

Founded in 1977 and headquartered in St. Paul, Minnesota, MGC Diagnostics is a leading provider of cardiorespiratory diagnostic solutions, known for its innovative technologies and superior customer support in the detection, diagnosis and management of respiratory conditions. The company's product portfolio spans pulmonary function testing, cardiopulmonary exercise testing, body plethysmography and FeNO testing. Its Ascent Software Solutions™ - the most advanced cardiorespiratory software on the market - connects that data into one diagnostic ecosystem, simplifying clinical workflows and helping care teams manage patients with confidence.

About Monitored Therapeutics, Inc. (MTI)

Based in Dublin, Ohio, Monitored Therapeutics unifies respiratory testing across clinic and home with real-time coaching and centralized clinical oversight on a single platform. Its solutions include the GoSpiro® spirometer, GoClinic® point-of-care platform, GoMobile™ home-testing application and Lisa real-time coaching technology. MTI helps healthcare organizations and clinical research programs obtain more consistent, high-quality respiratory data across operators, locations and care settings. Learn more at monitoredrx.com.